glp 1 lemme GLP-1 Daily™ Lemme GLP-1 Daily Review: What
Description
OZEMPIC (semaglutide) injection, for subcutaneous use
Methods 4 , 923925 (2007)
Baker, T
For type 2 diabetes, NICE-recommended alternatives include metformin (first-line), SGLT2 inhibitors, DPP-4 inhibitors, and insulin therapy, each with distinct mechanisms and side-effect profiles
It includes digital consultations and ongoing care but does not include the cost of medication itself
